Fig. 7 | Scientific Reports

Fig. 7

From: SHC1 serves as a prognostic and immunological biomarker in clear cell renal cell carcinoma: a comprehensive bioinformatics and experimental analysis

Fig. 7

Immune assessment and sensitivity to immunotherapy of SHC1. (A) Expression of common immune checkpoints in high- and low- expression of SHC1. (B) Distribution of SHC1 expression in TIDE scores. (C) Distribution of SHC1 expression in MSI scores. (D) Distribution of SHC1 expression in T-cell exclusion scores. (E) Distribution of SHC1 expression in T-cell dysfunction scores. (F) Distribution of SHC1 expression in CTLA4-positive and PD1-positive scores. (G) Distribution of SHC1 expression in CTLA4-positive and PD1-negative scores. (H) Distribution of SHC1 expression in CTLA4-negative and PD1-positive scores. (I) Distribution of SHC1 expression in CTLA4-negative and PD1-negative scores.

Back to article page